• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Sonida Senior Living Inc.

    2/13/26 4:04:13 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care
    Get the next $SNDA alert in real time by email
    8-K
    false 0001043000 0001043000 2026-02-13 2026-02-13
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 13, 2026

     

     

    Sonida Senior Living, Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   1-13445   75-2678809
    (State or Other Jurisdiction
    of Incorporation)
     

    (Commission

    File Number)

      (IRS Employer
    Identification No.)

    14755 Preston Road

    Suite 810

    Dallas, Texas

        75254
    (Address of Principal Executive Offices)     (Zip Code)

    Registrant’s Telephone Number, Including Area Code: (972) 770-5600

     

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

     

    ☒

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     


    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.01 per share   SNDA   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

     

     
     


    Item 8.01

    Other Events

    As previously reported, on November 4, 2025, Sonida Senior Living, Inc. (“SNDA”), and CNL Healthcare Properties, Inc. (“CHP”), entered into an Agreement and Plan of Merger (as amended from time to time, the “Merger Agreement”), by and among SNDA, CHP, SSL Sparti LLC, a wholly owned subsidiary of SNDA (“Holdco”), SSL Sparti Property Holdings Inc., a wholly owned subsidiary of Holdco (f/k/a Sparti Merger Sub, Inc., “SNDA Merger Sub”), and CHP Merger Corp., a wholly owned subsidiary of CHP (“CHP Merger Sub”).

    On December 17, 2025, SNDA filed a preliminary joint proxy statement/prospectus with the Securities and Exchange Commission (“SEC”), a revised version of which was filed with the SEC on January 2, 2026 (as revised, the “Preliminary Proxy Statement”). On January 6, 2026, SNDA filed a definitive joint proxy statement/prospectus (the “Definitive Proxy Statement”) with the SEC in connection with the special meeting of SNDA stockholders to be held virtually on February 26, 2026 at 10:00 a.m. Eastern Time (the “SNDA Special Meeting”), which meeting can be accessed by visiting meetnow.global/MNXNNRP. Capitalized terms used below, unless otherwise defined, shall have the meanings ascribed to such terms in the Definitive Proxy Statement.

    Following the filing of the Definitive Proxy Statement, and as of the date of this Current Report on Form 8-K, two lawsuits have been filed by purported stockholders of SNDA against SNDA and members of SNDA’s Board of Directors in the Supreme Court of the State of New York (captioned Williams v. Sonida Senior Living, Inc., et al., No. 650669/2026, and Ballard v. Sonida Senior Living, Inc., et al., No. 650590/2026) (collectively, the “Actions”). The Actions generally allege, among other things, that the Definitive Proxy Statement omits material information regarding the proposed transactions contemplated by the Merger Agreement (the “Transactions”) and seek, among other things, an injunction enjoining the SNDA Special Meeting until such time as the alleged disclosure deficiencies are corrected, rescission of the Transactions or damages in the event the Transactions are consummated, and an award of costs, including reasonable attorneys’ and experts’ fees. SNDA has also received demand letters from purported stockholders (collectively, the “Shareholder Letters”) alleging, among other things, that the disclosures contained in the Preliminary Proxy Statement and/or the Definitive Proxy Statement are deficient and demanding that certain corrective disclosures be made. SNDA believes that the allegations in the Shareholder Letters and the Actions are without merit, that each of the Preliminary Proxy Statement and the Definitive Proxy Statement complies with applicable law, and that no further disclosure is required. However, solely in order to mitigate any risk of the Actions and the Shareholder Letters delaying or otherwise adversely affecting the consummation of the Transactions and to minimize any costs, risks, and uncertainties inherent in any litigation related thereto, and without admitting any liability or wrongdoing, SNDA and CHP have determined to voluntarily supplement the Definitive Proxy Statement as described in this Current Report on Form 8-K. Nothing in this Current Report on Form 8-K shall be deemed an admission of the legal necessity or materiality under applicable laws of any of the disclosures set forth herein. To the contrary, SNDA specifically denies all allegations in the Actions and the Shareholder Letters and any assertion that additional disclosure was or is required.

    These supplemental disclosures will not change the consideration to be paid to CHP stockholders in connection with the Transactions or the timing of the SNDA Special Meeting. The Board continues to recommend that you vote “FOR” each of the proposals to be voted on at the SNDA Special Meeting described in the Definitive Proxy Statement.

    The information contained in this Current Report on Form 8-K is incorporated by reference into the Definitive Proxy Statement. To the extent that information in this Current Report on Form 8-K differs from or updates information contained in the Definitive Proxy Statement, the information in this Current Report on Form 8-K shall supersede or supplement such information in the Definitive Proxy Statement.

     


    Supplement to Definitive Proxy Statement

    This supplemental information should be read in conjunction with the disclosures contained in the Definitive Proxy Statement, which in turn should be read in its entirety. All page references are to the Definitive Proxy Statement. New text within restated language from the Definitive Proxy Statement is indicated in bold, underlined text (e.g., bold, underlined text) and removed language within the restated language from the Definitive Proxy Statement is indicated in strikethrough text (e.g., strikethrough text), as applicable. The information contained herein speaks only as of February 13, 2026 unless the information indicates another date applies.

    The third full paragraph on Page 121, under “The Transactions – Background of the Transactions,” is hereby amended and supplemented as follows:

    On April 4, 2025, CHP and SNDA entered into a confidentiality agreement regarding the confidentiality of CHP information. This confidentiality agreement included a 12-month standstill provision with a customary “don’t ask, don’t waive” provision.

    The third full paragraph on Page 122, under “The Transactions – Background of the Transactions,” is hereby amended and supplemented as follows:

    On June 15, 2025, CHP and SNDA entered into a confidentiality agreement regarding the confidentiality of SNDA information. This confidentiality agreement included a 12-month standstill provision with a customary “don’t ask, don’t waive” provision.

    The second sentence of the first full paragraph on page 154 under “Opinion of SNDA’s Financial Advisor – Financial Analyses – CHP Financial Analyses – Selected Public Companies Analysis” is hereby amended and supplemented as follows:

    The overall weighted average low to high calendar year 2026 estimated FFO, calendar year 2026 estimated AFFO and calendar year 2026 estimated EBITDA multiples observed for the CHP selected companies deemed meaningful were 17.8x to 22.2x, 21.1x to 24.9x and 18.1x to 20.1x, respectively, based on the following:

     

         CY2026E FFO      CY2026E AFFO      CY2026E EBITDA  
    Selected SHOP Companies         

    • American Healthcare REIT, Inc.

         24.4x        27.9x        21.8x  

    • Ventas, Inc.

         19.7x        24.0x        19.7x  

    • Welltower Inc.

         30.5x        35.0x        28.8x  
    Selected NNN Companies         

    • LTC Properties, Inc.

         12.7x        12.4x        12.7x  

    • National Health Investors, Inc.

         14.8x        14.6x        14.6x  

    • Sabra Health Care REIT, Inc.

         11.5x        11.6x        13.4x  

    The first sentence of the second full paragraph on page 154 under “Opinion of SNDA’s Financial Advisor – Financial Analyses – CHP Financial Analyses – Selected Public Companies Analysis” is hereby amended and supplemented as follows:

    No company or business used in this analysis is identical to CHP nor, except for selected multiples applied in deriving implied equity value per share reference ranges, were individual multiples of the CHP selected companies independently determinative of the results of such analysis.


    The second and third sentences of the third full paragraph on page 154 under “Opinion of SNDA’s Financial Advisor – Financial Analyses – CHP Financial Analyses – Discounted Cash Flow Analysis” is hereby amended and supplemented as follows:

    The implied terminal value of CHP was derived by applying to CHP’s unlevered, after-tax free cash flow for the fiscal year ending December 31, 2030 a selected range of perpetuity growth rates of 3.0% to 4.0% selected based on RBC Capital Markets’ professional judgment. The unlevered, after-tax free cash flows and terminal value were then discounted to present value (as of December 31, 2025) using a selected range of discount rates of 8.5% to 9.5% derived from a weighted average cost of capital calculation.

    The first sentence of the second full paragraph on page 155 under “Opinion of SNDA’s Financial Advisor – Financial Analyses – SNDA Financial Analyses – Selected Public Companies Analysis” is hereby amended and supplemented as follows:

    The overall low to high calendar year 2026 estimated FFO, calendar year 2026 estimated AFFO and calendar year 2026 estimated EBITDA multiples observed for the SNDA selected companies deemed meaningful were 19.7x to 30.5x (with a mean of 24.9x and a median of 24.4x), 24.0x to 35.0x (with a mean of 29.0x and median of 27.9x) and 14.1x to 28.8x (with a mean of 21.1x and a median of 20.7x), respectively, based on the following (information not publicly available is designated below as “NA”):

     

         CY2026E FFO    CY2026E AFFO    CY2026E EBITDA

    • American Healthcare REIT, Inc.

       24.4x    27.9x    21.8x

    • Brookdale Senior Living Inc.

       NA    NA    14.1x

    • Ventas, Inc.

       19.7x    24.0x    19.7x

    • Welltower Inc.

       30.5x    35.0x    28.8x

    The first sentence of the third full paragraph on page 155 under “Opinion of SNDA’s Financial Advisor – Financial Analyses – SNDA Financial Analyses – Selected Public Companies Analysis” is hereby amended and supplemented as follows:

    No company or business used in this analysis is identical to SNDA nor, except for selected multiples applied in deriving implied equity value per share reference ranges, were individual multiples of the SNDA selected companies independently determinative of the results of such analysis.

    The third and fourth sentences of the fourth full paragraph on page 155 under “Opinion of SNDA’s Financial Advisor – Financial Analyses – SNDA Financial Analyses – Discounted Cash Flow Analysis” is hereby amended and supplemented as follows:

    The implied terminal value of SNDA was derived by applying to SNDA’s unlevered, after-tax free cash flow for the fiscal year ending December 31, 2030 a selected range of perpetuity growth rates of 3.5% to 4.5% selected based on RBC Capital Markets’ professional judgment. The unlevered, after-tax free cash flows and terminal value were then discounted to present value (as of December 31, 2025) using a selected range of discount rates of 9.0% to 10.0% derived from a weighted average cost of capital calculation.

    The second sentence of the last paragraph beginning on page 155 under “Opinion of SNDA’s Financial Advisor – Financial Analyses – SNDA Financial Analyses – Illustrative Intrinsic-Based Value Creation” is hereby amended and supplemented as follows:

    For purposes of this comparison, RBC Capital Markets utilized a selected perpetuity growth rate range of 3.25% to 4.25% selected based on RBC Capital Markets’ professional judgment and a selected discount rate range of 8.5% to 9.5% derived from a weighted average cost of capital calculation and otherwise performed such comparison in a manner consistent with the approach undertaken in connection with the discounted cash flow analysis conducted for SNDA on a standalone basis described above under “– SNDA – Discounted Cash Flow Analysis.”

    The first sentence of the second full paragraph on page 156 under “Opinion of SNDA’s Financial Advisor – Miscellaneous” is hereby amended and supplemented as follows:

    As the SNDA Board was aware, RBC Capital Markets and/or its affiliates in the past have provided, currently are providing and in the future may provide investment banking, commercial banking and/or financial advisory services to SNDA unrelated to the Transactions and to certain significant stockholders of SNDA (including

     


    Conversant) and/or certain of their respective portfolio companies, as applicable, for which services RBC Capital Markets and its affiliates have received and would expect to receive compensation, including, during the approximate two-year period preceding the date of RBC Capital Markets’ opinion, having acting or acted or acting as a (i) bookrunner for a follow-on offering of SNDA Common Stock and (ii) lender to SNDA and a portfolio company of Conversant under certain credit facilities, for which services described in clauses (i) and (ii) RBC Capital Markets and/or its affiliates received during such two-year period aggregate fees of approximately $8 million. During the approximate two-year period preceding the date of RBC Capital Markets’ opinion, RBC Capital Markets and its affiliates had not provided investment banking, commercial banking and/or financial advisory services to Silk for which RBC Capital Markets and/or its affiliates received compensation.

    The first full paragraph and following table on Page 159, under “Unaudited Prospective Financial Information Prepared by SNDA – Projections for Standalone SNDA” is hereby amended and supplemented as follows:

    The following table sets forth certain summarized unaudited prospective financial information with respect to SNDA for the calendar years 2025 through 2030 on a standalone basis prepared by SNDA’s senior management.

     

    (in millions)    2025E      2026E      2027E      2028E      2029E      2030E  

    Revenue

       $ 334.6      $ 365.9      $ 393.3      $ 419.9      $ 438.0      $ 454.2  

    EBITDA(1)

       $ 44.4      $ 64.6      $ 79.5      $ 93.1      $ 99.3      $ 104.9  

    (+) Stock-Based Compensation

       $  5.9      $  6.0      $  6.2      $  6.3      $  6.5      $  6.6  

    (+) Bad Debt Expense

       $  3.0      $  3.4      $  3.2      $  2.9      $  2.7      $  2.8  

    Adjusted EBITDA(2)

       $ 53.3      $ 74.1      $ 88.8      $ 102.3      $ 108.5      $ 114.3  

    Unlevered Free Cash Flow(3)

         —      $ 44      $ 57      $ 67      $ 71      $ 75  

     

    (1)

    EBITDA is defined as net income (loss) excluding depreciation and amortization expense, interest income, interest expense, other expense/income and provision for income taxes. EBITDA is a non-GAAP financial measure as it excludes amounts included in net income (loss), the most directly comparable measure calculated in accordance with GAAP. This measure should not be considered as an alternative to net income (loss) or other measures derived in accordance with GAAP.

    (2)

    Adjusted EBITDA is defined as EBITDA further adjusted to exclude for income/expense associated with non-cash, non-operational, transactional, or organizational restructuring items, include such as stock-based compensation expense, provision for credit losses, casualty losses, transaction, transition and restructuring costs and impairment of assets held for sale, that SNDA management does not consider as part of SNDA’s underlying core operating performance and that SNDA management believes impact the comparability of performance between periods. Adjusted EBITDA is a non-GAAP financial measure as it excludes amounts included in net income (loss), the most directly comparable measure calculated in accordance with GAAP. This measure should not be considered as an alternative to net income (loss) or other measures derived in accordance with GAAP.

    (3)

    Unlevered Free Cash Flow is defined as net cash provided by operating activities, less capital expenditures and capitalized software, plus after-tax interest expense. Unlevered Free Cash Flow is a non-GAAP financial measure as it adjusts amounts included in net cash provided by operating activities, the most directly comparable measure calculated in accordance with GAAP. This measure should not be considered as an alternative to net cash provided by operating activities or other measures derived in accordance with GAAP.

    Following the first full paragraph and corresponding table on Page 159, under “Unaudited Prospective Financial Information Prepared by SNDA – Projections for Standalone SNDA,” a new paragraph is hereby added as follows:

    The following table sets forth certain summarized unaudited prospective financial information with respect to SNDA on a standalone basis prepared by SNDA’s senior management with respect to SNDA’s projected 10-year utilization of net operating losses.

     

    (in millions)    2026E    2027E    2028E    2029E    2030E    2031E    2032E    2033E    2034E    2035E

    NOL Utilization

       $0.0    $1.5    $17.5    $21.0    $25.1    $24.9    $25.6    $26.3    $27.1    $24.8

    * * * * * *

     


    No Offer or Solicitation

    This communication is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Transactions and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy, sell or solicit any securities or any proxy, vote or approval in any jurisdiction pursuant to or in connection with the Transactions or otherwise, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

    Additional Information and Where to Find It

    This communication relates to the Transactions involving SNDA and CHP. In connection with the Transactions, SNDA and CHP have filed the Definitive Proxy Statement with the SEC on January 6, 2026, which was declared effective by the SEC on January 6, 2026. After filing its Definitive Proxy Statement with the SEC, SNDA and CHP mailed the Definitive Proxy Statement to the stockholders of SNDA and the stockholders of CHP seeking their respective approval of the Transactions. SNDA and CHP may also file other documents regarding the Transactions with the SEC. This communication is not intended to be, and is not, a substitute for such filings or for any other document that SNDA and/or CHP may file with the SEC in connection with the Transactions. BEFORE MAKING ANY VOTING DECISION, SNDA’S AND CHP’S RESPECTIVE STOCKHOLDERS ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE DEFINITIVE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS AND ANY OTHER RELEVANT DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTIONS WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT SNDA, CHP AND THE TRANSACTIONS.

    Investors and shareholders may obtain copies of these documents and other documents filed by SNDA and CHP with the SEC free of charge through the website maintained by the SEC at www.sec.gov or from SNDA at its website, sonidaseniorliving.com, under the heading Investor Relations, or from CHP at its website, cnlhealthcareproperties.com, under the heading Investor Resources.

    NEITHER THE SEC NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED IN THIS COMMUNICATION, PASSED UPON THE MERITS OR FAIRNESS OF THE TRANSACTIONS OR RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS COMMUNICATION. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.

    Participants in the Solicitation

    SNDA and CHP, their respective directors and certain of their respective executive officers may be deemed to be participants in the solicitation of proxies in connection with the Transactions under the rules of the SEC. Information about the interests of the directors and executive officers of SNDA and CHP and other persons who may be deemed to be participants in the solicitation of proxies in connection with the Transactions and a description of their direct and indirect interests, by security holdings or otherwise, can be found in the sections entitled “The Transactions – Interests of SNDA’s Directors and Executive Officers in the Transactions” and “The Transactions – Interests of CHP’s Directors and Executive Officers in the Transactions” included in the Definitive Proxy Statement (and which is available at https://www.sec.gov/Archives/edgar/data/1043000/000119312526003544/d938110d424b3.htm). Information about the directors and executive officers of SNDA and their ownership of SNDA equity interests can be found in the sections entitled “Principal Stockholders and Stock Ownership of Management,” “Executive Officers,”


    “Executive Compensation Tables,” and “2024 Director Compensation” included in SNDA’s definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders, filed with the SEC on April 29, 2025; in the Form 3 and Form 4 statements of beneficial ownership and statements of changes in beneficial ownership filed with the SEC by SNDA’s directors and executive officers; and in other documents filed by SNDA with the SEC. Information about the directors and executive officers of CHP and their ownership of CHP equity interests is set forth in the sections entitled “CHP Directors and Executive Officers” under “Information about CHP” and “Security Ownership of CHP Directors and Management” “included in the Definitive Proxy Statement.

    Cautionary Note Regarding Forward-Looking Statements

    This communication contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements that include the words “expect,” “will,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “could,” “should,” “anticipate” and similar statements of a future or forward-looking nature. The forward-looking statements, are subject to certain risks and uncertainties, and actual results, events and financial condition could materially differ from those indicated in the forward-looking statements, including, among others, (1) the termination of or occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement, or the inability to complete the Transactions on the anticipated terms or by the end of the Outside Date (as defined in the Merger Agreement), (2) the inability to complete the Transactions due to the failure to satisfy all of the conditions to closing in a timely manner or at all, including the failure to obtain the requisite stockholder approvals or to obtain the Equity Financing (as defined in the Merger Agreement), or the risk that a regulatory approval that may be required for the Transactions is delayed, is not obtained or is obtained subject to conditions that are not anticipated, (3) costs related to the Transactions, including costs with respect to the Equity Financing, (4) the diversion of management’s time and attention from ordinary course business operations to completion of the Transactions and integration matters, (5) the risk of litigation action related to the Transactions, (6) such other economic or other conditions in the markets CHP or SNDA are engaged in, (7) the risks, uncertainties and factors set forth under “Item. 1A. Risk Factors” in SNDA’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 17, 2025, and as such factors may be updated from time to time in SNDA’s other filings with the SEC, and (8) the risks, uncertainties and factors set forth under “Item. 1A. Risk Factors” in CHP’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 5, 2025, and as such factors may be updated from time to time in CHP’s other filings with the SEC, which filings are accessible on the SEC’s website at www.sec.gov. This list of factors is not intended to be exhaustive. Forward-looking statements only speak as of the date of this communication, and neither CHP nor SNDA assumes any obligation to update any written or oral forward-looking statement made by either SNDA or on its behalf or CHP or on its behalf as a result of new information, future events or other factors, except as required by law.

     

    Item 9.01

    Financial Statements and Exhibits.

     

    Exhibit

    Number

      

    Description

    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        SONIDA SENIOR LIVING, INC.
    Date: February 13, 2026     By:  

    /s/ Brandon M. Ribar

          Brandon M. Ribar
          Chief Executive Officer and President
    Get the next $SNDA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNDA

    DatePrice TargetRatingAnalyst
    1/9/2026Neutral
    Robert W. Baird
    12/13/2024$25.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $SNDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sonida Senior Living to Participate in the Morgan Stanley 9th Annual CRE Conference

    Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner, operator and investor in senior living communities, announced today that Brandon Ribar, President & Chief Executive Officer, Kevin Detz, Chief Financial Officer and Max Levy, Chief Investment Officer, will participate in Morgan Stanley's Annual Commercial Real Estate Conference on Wednesday, February 18th and Thursday, February 19th at the Morgan Stanley Headquarters in New York City. Management is available for one-on-one meetings with institutional investors during the conference. To schedule a meeting, please contact your bank representative. About Sonida Dallas-based Sonida Senior Living, Inc. is

    2/5/26 8:30:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Announces $900 Million of Permanent Debt Financing Commitments in Connection with CNL Healthcare Properties, Inc. Strategic Merger

    Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner, operator and investor in senior living communities, announced today that in connection with the previously announced definitive merger agreement (the "Merger Agreement") with CNL Healthcare Properties, Inc. ("CHP"), Sonida has obtained committed permanent debt financing ("Permanent Facilities") of $900 million, with a $350 million accordion feature that allows Sonida to increase the facilities up to $1.25 billion. As previously communicated on November 5, 2025, Sonida will acquire 100% of the outstanding common stock of CHP for stock and cash consideration valued at approximately $1.8 billion. At the time

    1/5/26 8:05:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Celebrates Grand Opening and a New Era of Trusted Memory Care at Magnolia Trails at East Lake

    Magnolia Trails at East Lake celebrated its grand opening on November 13, marking an exciting new chapter for families seeking trustworthy and high-quality memory care in Tarpon Springs, FL. More than 120 guests attended, including the Tarpon Springs Chamber of Commerce and over 65 healthcare partners from across the Tampa Bay region. The event showcased the community's beautiful spaces and amenities as well as its renewed direction under Sonida Senior Living ("Sonida"), which acquired the community in May 2025. Since taking ownership, Sonida has focused on establishing stability and building trust with residents and their families in addition to continued investment upgrades into the bui

    12/29/25 8:15:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Ribar Brandon covered exercise/tax liability with 809 shares and returned 14,657 shares to the company, decreasing direct ownership by 5% to 311,710 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    9/10/25 7:51:38 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    VP & Chief Accounting Officer Cober Timothy covered exercise/tax liability with 187 shares, decreasing direct ownership by 0.46% to 40,774 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    7/23/25 4:52:33 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Director Zibel Elliot R was granted 2,985 shares, increasing direct ownership by 35% to 11,608 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    6/12/25 8:01:52 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $SNDA
    SEC Filings

    View All

    $SNDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    President & CEO Ribar Brandon bought $98,668 worth of shares (4,000 units at $24.67), increasing direct ownership by 1% to 327,176 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    5/23/25 9:47:19 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Director Simanovsky Michael bought $897,835 worth of shares (42,111 units at $21.32) (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    1/13/25 2:06:54 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    President & CEO Ribar Brandon bought $90,720 worth of shares (4,000 units at $22.68), increasing direct ownership by 1% to 315,469 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    11/19/24 4:47:54 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    SEC Form 425 filed by Sonida Senior Living Inc.

    425 - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    2/13/26 4:06:48 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    SEC Form 8-K filed by Sonida Senior Living Inc.

    8-K - SONIDA SENIOR LIVING, INC. (0001043000) (Filer)

    2/13/26 4:04:13 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    SEC Form EFFECT filed by Sonida Senior Living Inc.

    EFFECT - SONIDA SENIOR LIVING, INC. (0001043000) (Filer)

    1/7/26 12:15:17 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Robert W. Baird initiated coverage on Sonida Senior Living

    Robert W. Baird initiated coverage of Sonida Senior Living with a rating of Neutral

    1/9/26 9:07:37 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Morgan Stanley initiated coverage on Sonida Senior Living with a new price target

    Morgan Stanley initiated coverage of Sonida Senior Living with a rating of Equal-Weight and set a new price target of $25.00

    12/13/24 8:22:29 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Leadership Updates

    Live Leadership Updates

    View All

    Sonida Enhances Executive Team and Board to Support Company Growth

    Max Levy appointed Chief Investment Officer in newly created role Lilly H. Donohue, a long-time senior living industry executive, to join Board of Directors Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner-operator and investor in communities and services for seniors, today announced the appointment of Max Levy to the newly created role of Chief Investment Officer ("CIO"). In addition, the Company also announced today that Lilly H. Donohue will be appointed to the Board. As CIO and a member of the executive committee, Mr. Levy, who is transitioning to Sonida from his role as a Principal at Conversant Capital ("Conversant"), the Company's largest shar

    5/10/24 5:30:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Names Tabitha Obenour Chief Clinical Officer

    Expands Sonida's Leadership Team with Robust Clinical Operations Expertise Sonida Senior Living, Inc. (the "Company" or "Sonida Senior Living") (NYSE:SNDA), a leading owner-operator of senior living communities and services, announced the appointment of Tabitha Obenour as Vice President and Chief Clinical Officer, effective November 1, 2023. Obenour joins Sonida from senior living provider Enlivant where she served as the company's Vice President of Clinical Quality and Compliance. "As our company continues to look for growth opportunities, operational excellence and resident care remain our highest priorities. A clinical leader with 20 years' experience, Tabitha has a deep understandin

    11/3/23 8:49:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Announces Leadership Transition

    CEO Kim Lody to step down after eight years with the Company Brandon Ribar promoted from COO to CEO Sonida Senior Living, Inc. (the "Company" or "Sonida") (NYSE:SNDA), one of the nation's leading senior living owner-operators, announced that Kimberly S. Lody has decided to step down after an eight-year tenure with the Company, including approximately three and a half years as Chief Executive Officer (CEO). In accordance with the Company's succession plan, Brandon M. Ribar, the Company's Chief Operating Officer (COO), has been appointed President and CEO, effective September 2, 2022. Lody will continue to serve in her current role through September 2, 2022, to ensure a smooth transition. Ri

    8/4/22 5:00:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Sonida Senior Living Inc.

    SC 13D/A - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    10/17/24 5:33:31 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Sonida Senior Living Inc.

    SC 13D/A - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    8/21/24 7:18:19 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Sonida Senior Living Inc.

    SC 13D/A - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    8/19/24 4:26:52 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Financials

    Live finance-specific insights

    View All

    Sonida Senior Living Announces Third Quarter 2025 Results

    Sonida Senior Living, Inc. (the "Company," "Sonida," "we," "our," or "us") (NYSE:SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the third quarter ended September 30, 2025. "In the third quarter, total portfolio community NOI grew approximately 21%, driven by solid rent growth and strong results in the acquisition portfolio," said Brandon Ribar, President and CEO. "In the same-store portfolio, occupancy achieved its highest levels post-Covid at 87.7%, with end of October spot occupancy reaching 89.0%. Execution on our acquisition strategy continued in September with the addition of a high-quality senior housing community in the D

    11/10/25 8:15:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator

    2026E Normalized FFO Accretion of 28% to 62% Based on an Asymmetric Collar with Substantial Near-Term and Future Synergies Strengthens Balance Sheet Through Immediate Deleveraging and Significantly Deepens Access to Capital Transaction Funded with 66% Stock and 34% Cash; Financing for Cash Portion is Committed with Debt Financing from RBC and BMO and Equity Commitments from Sonida's Two Largest Shareholders Creates Eighth Largest Owner of U.S. Senior Living Assets1 Sonida President & CEO Brandon Ribar and Existing Sonida Management Team to Lead Combined Company Sonida Provides Highlights of Preliminary Q3'25 Results Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a

    11/5/25 7:30:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Announces Third Quarter 2025 Earnings Release Date and Conference Call

    Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner, operator and investor in communities and services for seniors, today announced that it will issue its third quarter 2025 earnings results before the market opens for trading on Monday, November 10, 2025. The Company will then host a conference call and webcast to review its financial performance and operating results at 11:00 a.m. Eastern Time. The dial-in number for the conference call is (800) 715-9871 (or +1 (646) 307-1963 for international callers), and the participant passcode is 4619110. A live webcast can be accessed here. All participants are asked to register and connect 10 minutes prior to the s

    10/30/25 8:15:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care